Program By Day

7:00 AM-8:00 AM Complimentary Continental Breakfast
7:00 AM-6:30 PM Exhibits Open
7:50 AM-9:30 AM Welcome and General Session 1: Response Assessment and Individualization of Management of Esophageal Adenocarcinoma (ARS)

Sarah E. Hoffe, MD - Chair
H. Lee Moffitt Cancer Center and Research Institute

Gail Elizabeth Darling, MD - Chair
University of Toronto

Laura A. Dawson, MD
Princess Margaret Cancer Centre
Welcome of the Day

Case Presentation

Kenneth Wang, MD
Mayo Clinic
Initial Staging and Response Assessment

Debate: Management of Esophageal Adenocarcinoma After Neoadjuvant Therapy With Complete Clinical Response—Surgery Versus Watchful Waiting

Andrew Barbour, MBBS, PhD, FRACS, FACS
University of Queensland
Surgeon Perspective

Florence Huguet, MD, PhD
Hôpital Tenon
Radiation Oncologist Perspective

David H. Ilson, MD, PhD
Memorial Sloan Kettering Cancer Center
Improving Esophageal Adenocarcinoma Outcomes: Future Directions

Panel Question and Answer
9:30 AM-10:00 AM Break
10:00 AM-11:30 AM

General Session 2: Global Outlook on Gastric Cancer

Ulysses Ribeiro Jr., MD, PhD - Chair
University of São Paulo

Khaldoun Almhanna, MD, MPH - Chair
Moffitt Cancer Center

Global Perspectives on Surveillance, Risk Factors, and Management of Early Gastric Cancer

Alexander G. Meining, MD
Medical School of the University of Ulm
European Perspective

Paola Catherine Montenegro, MD
Instituto Nacional de Enfermedades Neoplasicas
South American Perspective

Seiichiro Abe, MD
National Cancer Center Hospital
Asian Perspective

Margaret Gulley, MD
University of North Carolina School of Medicine
Capitalizing on Epstein-Barr Virus to Better Classify, Treat, and Monitor Gastric Cancer

 

Abstract 1: Long-term outcome of a randomized phase III trial exploring the significance of extensive intraoperative peritoneal lavage in addition to standard treatment for ≥ T3 resectable gastric cancer: CCOG 1102.

First author: Daishi Morimoto, MD 

Panel Question and Answer

11:30 AM-1:00 PM Poster Session A: Cancers of the Esophagus and Stomach
With Complimentary Boxed Lunch
11:30 AM-1:00 PM Trials in Progress Poster Session A: Cancers of the Esophagus and Stomach
12:00 PM-1:00 PM Trainee and Early-Career Networking Luncheon
For a full list of participating faculty, please visit the Trainee & Early-Career Networking Luncheon page
1:00 PM-2:00 PM

Rapid-Fire Abstract Session: Cancers of the Esophagus and Stomach

Sarah E. Hoffe, MD - Chair
Moffitt Cancer Center

Ulysses Ribeiro, Jr., MD, PhD - Chair
University of Sao Paulo

 

Abstract 6: Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer: A randomized controlled trial.

First author: Pieter van der Sluis, MD, PhD, Msc

 

Question and Answer

 

Abstract 91: A prospective multicenter trial of S-1 with lafutidine vs S-1 as adjuvant chemotherapy for gastric cancer in Japan: AEOLUS.

First author: Nozomu Machida, MD, PhD

 

Question and Answer

 

Abstract 8: CYTO-CHIP: Cytoreductive surgery versus cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis: A propensity-score analysis from BIG RENAPE and FREGAT working groups.

First author: Pierre Emmanuel Bonnot, BA

 

Question and Answer

 

Abstract 9: Associations of PD-1 and PD-L1 expression with mismatch repair status and prognosis in chemoradiotherapy-naïve esophageal and gastric adenocarcinoma.

First author: Maria Svensson, MD, PhD Student 

 

Question and Answer

1:00 PM-2:00 PM Breakout Session: Multidisciplinary Management of Less Common Gastroesophageal Tumors

Shishir Maithel, MD, FACS - Chair
Emory University Winship Cancer Institute

Ronald P. DeMatteo, MD, FACS
University of Pennsylvania Hospital
Guidelines for Perioperative Imatinib Therapy for Gastrointestinal Stromal Tumors

Field F. Willingham, MD, MPH
Emory University School of Medicine
Evaluation of Gastroesophageal Submucosal Lesions and Minimally Invasive Management Options

Panel Question and Answer
1:00 PM-2:00 PM Breakout Session: FLOT or Not—Perioperative Management for Gastric Cancer

Salah-Eddin Al-Batran, MD
Institute of Clinical Cancer Research, Krankenhaus Nordwest, UCT-University Cancer Center
Pro

Jaffer A. Ajani, MD
University of Texas MD Anderson Cancer Center
Con

Panel Question and Answer
2:00 PM-2:15 PM Break
2:15 PM-3:45 PM

Oral Abstract Session A: Cancers of the Esophagus and Stomach

David H. Ilson, MD, PhD - Chair
Memorial Sloan Kettering Cancer Center

K. Robert Shen, MD - Chair
Mayo Clinic

 

Abstract 2: The impact of the chemoradiation to surgery interval on pathological complete response: Short and long-term overall survival in esophageal cancer patients.

First author: Basem Azab, BA

 

Abstract 3: Impact of lung and heart dose on survival after radiotherapy for esophageal cancer.

First author: Patrick Oh, BSc

 

Theodore S. Hong, MD

NSABP/ NRG Oncology/ Massachusetts General Hospital

Discussion

 

Abstract 4: Intraperitoneal immunotherapy with the bispecific anti-EpCAM x anti-CD3 directed antibody catumaxomab for patients with peritoneal carcinomatosis from gastric cancer: Final results of a randomized phase II AIO trial.

First author: Florian Lordick, MD

 

Abstract 5: RAINFALL: A randomized, double-blind, placebo-controlled phase III study of cisplatin (Cis) plus capecitabine (Cape) or 5FU with or without ramucirumab (RAM) as first-line therapy in patients with metastatic gastric or gastroesophageal junction (G-GEJ) adenocarcinoma.

First author: Charles Fuchs, MD

 

Stephen Leong, MD

University of Colorado Comprehensive Cancer Center

Discussion 

 

Panel Question and Answer

3:45 PM-4:15 PM Break
4:15 PM-5:30 PM General Session 3: Is There a Role for Locoregional Therapies in Stage IV Esophageal and Gastric Cancers? (ARS)

Paola Catherine Montenegro, MD - Chair
Instituto Nacional de Enfermedades Neoplasicas

Manisha Palta, MD - Chair
Duke University Medical Center

Case Presentation and Discussion

Brian D. Badgwell, MD
University of Texas MD Anderson Cancer Center
Surgical Oncologist Perspective

Elena Elimova, MD
Princess Margaret Cancer Centre
Medical Oncologist Perspective

Maria A Hawkins, FRCR, MD, MRCP
CRUK/MRC Oxford Institute for Radiation Oncology
Radiation Oncologist Perspective
5:30 PM-6:30 PM Poster Session A: Cancers of the Esophagus and Stomach
With Complimentary Wine and Cheese Reception
5:30 PM-6:30 PM Trials in Progress Poster Session A: Cancers of the Esophagus and Stomach
5:45 PM-6:30 PM

Poster Walks

Open to all attendees. Meet at the Poster Assistance Desk. 

 

Khaldoun Almhanna, MD, MPH

Moffitt Cancer Center 

 

K. Robert Shen, MD

Mayo Clinic